RET and central nervous system neoplasm: This case illustrates the diagnostic and therapeutic challenges posed by rare, highly aggressive CNS neoplasms that do not map to a WHO-defined entity on available testing and highlights the potential clinical relevance of identifying actionable <i>RET</i> fusions in high-grade neuroepithelial tumors.